Class information for: |
Basic class information |
Class id | #P | Avg. number of references |
Database coverage of references |
---|---|---|---|
23049 | 360 | 33.0 | 66% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
3 | 4 | PLANT SCIENCES//AGRONOMY//FOOD SCIENCE & TECHNOLOGY | 1882812 |
409 | 3 | BERBERINE//ALKALOIDS//RUTACEAE | 29426 |
2148 | 2 | IBOGAINE//SALVINORIN A//SALVIA DIVINORUM | 5021 |
23049 | 1 | IBOGAINE//NORIBOGAINE//18 METHOXYCORONARIDINE | 360 |
Terms with highest relevance score |
rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|---|
1 | IBOGAINE | authKW | 9377307 | 37% | 83% | 133 |
2 | NORIBOGAINE | authKW | 2544592 | 8% | 100% | 30 |
3 | 18 METHOXYCORONARIDINE | authKW | 1304910 | 6% | 77% | 20 |
4 | ISOQUINUCLIDINE | authKW | 624578 | 3% | 82% | 9 |
5 | TABERNANTHE IBOGA | authKW | 436214 | 2% | 86% | 6 |
6 | IBOGAMINE | authKW | 424099 | 1% | 100% | 5 |
7 | IBOGA ALKALOID | authKW | 415613 | 2% | 70% | 7 |
8 | CHIRAL ISOQUINUCLIDINES | authKW | 339279 | 1% | 100% | 4 |
9 | 1 2 DIHYDROPYRIDINE | authKW | 301844 | 3% | 32% | 11 |
10 | ELAEOCARPUS GANITRUS | authKW | 271422 | 1% | 80% | 4 |
Web of Science journal categories |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | Pharmacology & Pharmacy | 1665 | 40% | 0% | 145 |
2 | Chemistry, Organic | 957 | 24% | 0% | 87 |
3 | Neurosciences | 936 | 31% | 0% | 111 |
4 | Substance Abuse | 527 | 6% | 0% | 21 |
5 | Chemistry, Medicinal | 361 | 10% | 0% | 36 |
6 | Behavioral Sciences | 230 | 6% | 0% | 22 |
7 | Integrative & Complementary Medicine | 137 | 3% | 0% | 9 |
8 | Psychiatry | 126 | 8% | 0% | 28 |
9 | Medicine, Legal | 32 | 1% | 0% | 4 |
10 | Psychology, Biological | 27 | 1% | 0% | 4 |
Address terms |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | PHARMACOL NEUROSCI A136 | 271422 | 1% | 80% | 4 |
2 | NEUROL MOL CELLULAR PHARMACOL | 95418 | 1% | 38% | 3 |
3 | ANALYT TOXICOL CHEM | 89799 | 2% | 18% | 6 |
4 | ABORATING PSYCHOSOCIAL TORS DRUG A | 84820 | 0% | 100% | 1 |
5 | ADDICT HLTH CARE | 84820 | 0% | 100% | 1 |
6 | ANALLYT TOXICOL CHEM | 84820 | 0% | 100% | 1 |
7 | BEHAV NEUROGENET GRP | 84820 | 0% | 100% | 1 |
8 | BEHAV THER Y TREATMENT | 84820 | 0% | 100% | 1 |
9 | BRAIN IMAGING SECT INTRAMURAL PROGRAM | 84820 | 0% | 100% | 1 |
10 | HUMAN PHYSIOL PHARMACOL VITTORIO ERSPAME | 84820 | 0% | 100% | 1 |
Journals |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR | 2195 | 5% | 0% | 18 |
2 | EUROPEAN JOURNAL OF PHARMACOLOGY | 1437 | 6% | 0% | 22 |
3 | BRAIN RESEARCH | 1183 | 7% | 0% | 26 |
4 | PSYCHOPHARMACOLOGY | 834 | 3% | 0% | 11 |
5 | NATURAL PRODUCT LETTERS | 606 | 1% | 0% | 2 |
6 | ANNALS OF THE NEW YORK ACADEMY OF SCIENCES | 595 | 5% | 0% | 17 |
7 | TETRAHEDRON LETTERS | 584 | 6% | 0% | 23 |
8 | CNS DRUG REVIEWS | 518 | 0% | 1% | 1 |
9 | JOURNAL OF RELIGION IN AFRICA | 497 | 0% | 1% | 1 |
10 | JOURNAL OF ORGANIC CHEMISTRY | 402 | 4% | 0% | 16 |
Author Key Words |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | IBOGAINE | 9377307 | 37% | 83% | 133 | Search IBOGAINE | Search IBOGAINE |
2 | NORIBOGAINE | 2544592 | 8% | 100% | 30 | Search NORIBOGAINE | Search NORIBOGAINE |
3 | 18 METHOXYCORONARIDINE | 1304910 | 6% | 77% | 20 | Search 18+METHOXYCORONARIDINE | Search 18+METHOXYCORONARIDINE |
4 | ISOQUINUCLIDINE | 624578 | 3% | 82% | 9 | Search ISOQUINUCLIDINE | Search ISOQUINUCLIDINE |
5 | TABERNANTHE IBOGA | 436214 | 2% | 86% | 6 | Search TABERNANTHE+IBOGA | Search TABERNANTHE+IBOGA |
6 | IBOGAMINE | 424099 | 1% | 100% | 5 | Search IBOGAMINE | Search IBOGAMINE |
7 | IBOGA ALKALOID | 415613 | 2% | 70% | 7 | Search IBOGA+ALKALOID | Search IBOGA+ALKALOID |
8 | CHIRAL ISOQUINUCLIDINES | 339279 | 1% | 100% | 4 | Search CHIRAL+ISOQUINUCLIDINES | Search CHIRAL+ISOQUINUCLIDINES |
9 | 1 2 DIHYDROPYRIDINE | 301844 | 3% | 32% | 11 | Search 1+2+DIHYDROPYRIDINE | Search 1+2+DIHYDROPYRIDINE |
10 | ELAEOCARPUS GANITRUS | 271422 | 1% | 80% | 4 | Search ELAEOCARPUS+GANITRUS | Search ELAEOCARPUS+GANITRUS |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
---|---|---|---|---|
1 | ZUBARAN, C , (2000) IBOGAINE AND NORIBOGAINE: COMPARING PARENT COMPOUND TO METABOLITE.CNS DRUG REVIEWS. VOL. 6. ISSUE 3. P. 219 -240 | 82 | 95% | 9 |
2 | MACULAITIS, R , KONTRIMAVICIUTE, V , BRESSOLLE, FMM , BRIEDIS, V , (2008) IBOGAINE, AN ANTI-ADDICTIVE DRUG: PHARMACOLOGY AND TIME TO GO FURTHER IN DEVELOPMENT. A NARRATIVE REVIEW.HUMAN & EXPERIMENTAL TOXICOLOGY. VOL. 27. ISSUE 3. P. 181 -194 | 46 | 87% | 4 |
3 | ALPER, KR , STAJIC, M , GILL, JR , (2012) FATALITIES TEMPORALLY ASSOCIATED WITH THE INGESTION OF IBOGAINE.JOURNAL OF FORENSIC SCIENCES. VOL. 57. ISSUE 2. P. 398-412 | 60 | 51% | 25 |
4 | ALPER, KR , LOTSOF, HS , KAPLAN, CD , (2008) THE IBOGAINE MEDICAL SUBCULTURE.JOURNAL OF ETHNOPHARMACOLOGY. VOL. 115. ISSUE 1. P. 9-24 | 52 | 60% | 42 |
5 | LITJENS, RPW , BRUNT, TM , (2016) HOW TOXIC IS IBOGAINE?.CLINICAL TOXICOLOGY. VOL. 54. ISSUE 4. P. 297 -302 | 32 | 86% | 0 |
6 | SCHEP, LJ , SLAUGHTER, RJ , GALEA, S , NEWCOMBE, D , (2016) IBOGAINE FOR TREATING DRUG DEPENDENCE. WHAT IS A SAFE DOSE?.DRUG AND ALCOHOL DEPENDENCE. VOL. 166. ISSUE . P. 1 -5 | 32 | 86% | 0 |
7 | MASH, DC , AMEER, B , PROU, D , HOWES, JF , MAILLET, EL , (2016) ORAL NORIBOGAINE SHOWS HIGH BRAIN UPTAKE AND ANTI-WITHDRAWAL EFFECTS NOT ASSOCIATED WITH PLACE PREFERENCE IN RODENTS.JOURNAL OF PSYCHOPHARMACOLOGY. VOL. 30. ISSUE 7. P. 688 -697 | 26 | 81% | 0 |
8 | ANTONIO, T , CHILDERS, SR , ROTHMAN, RB , DERSCH, CM , KING, C , KUEHNE, M , BORNMANN, WG , ESHLEMAN, AJ , JANOWSKY, A , SIMON, ER , ET AL (2013) EFFECT OF IBOGA ALKALOIDS ON MU-OPIOID RECEPTOR-COUPLED G PROTEIN ACTIVATION.PLOS ONE. VOL. 8. ISSUE 10. P. - | 37 | 51% | 8 |
9 | CARNICELLA, S , HE, DY , YOWELL, QV , GLICK, SD , RON, D , (2010) NORIBOGAINE, BUT NOT 18-MC, EXHIBITS SIMILAR ACTIONS AS IBOGAINE ON GDNF EXPRESSION AND ETHANOL SELF-ADMINISTRATION.ADDICTION BIOLOGY. VOL. 15. ISSUE 4. P. 424-433 | 30 | 67% | 10 |
10 | KOENIG, X , HILBER, K , (2015) THE ANTI-ADDICTION DRUG IBOGAINE AND THE HEART: A DELICATE RELATION.MOLECULES. VOL. 20. ISSUE 2. P. 2208 -2228 | 31 | 50% | 8 |
Classes with closest relation at Level 1 |